Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yassir Al-Zubaidi

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmacological Reports : PR|July 30, 2022
The ixabepilone and vandetanib combination shows synergistic activity in docetaxel-resistant MDA-MB-231 breast cancer cellsStanton Tam, Yassir Al-Zubaidi, Md Khalilur Rahman, et al.
Journal of Pharmaceutical Sciences|June 14, 2022
Preclinical Evaluation of Ixabepilone in Combination with VEGF Receptor and PARP Inhibitors in Taxane-Sensitive and Taxane-Resistant MDA-MB-231 Breast Cancer CellsMd Khalilur Rahman, Yassir Al-Zubaidi, Kirsi Bourget, et al.
Cancer Letters|November 25, 2021
The aryl-ureido fatty acid CTU activates endoplasmic reticulum stress and PERK/NOXA-mediated apoptosis in tumor cells by a dual mitochondrial-targeting mechanismHassan Choucair, Md Khalilur Rahman, Balasubrahmanyam Umashankar, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 1, 2019
Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cellsYassir Al-Zubaidi, Curtis Pazderka, Nooshin Koolaji, et al.
Biochemical Pharmacology|August 14, 2021
PTU, a novel ureido-fatty acid, inhibits MDA-MB-231 cell invasion and dissemination by modulating Wnt5a secretion and cytoskeletal signalingYassir Al-Zubaidi, Yongjuan Chen, Md Khalilur Rahman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmacological Reports : PR|July 30, 2022
The ixabepilone and vandetanib combination shows synergistic activity in docetaxel-resistant MDA-MB-231 breast cancer cellsStanton Tam, Yassir Al-Zubaidi, Md Khalilur Rahman, et al.
Journal of Pharmaceutical Sciences|June 14, 2022
Preclinical Evaluation of Ixabepilone in Combination with VEGF Receptor and PARP Inhibitors in Taxane-Sensitive and Taxane-Resistant MDA-MB-231 Breast Cancer CellsMd Khalilur Rahman, Yassir Al-Zubaidi, Kirsi Bourget, et al.
Cancer Letters|November 25, 2021
The aryl-ureido fatty acid CTU activates endoplasmic reticulum stress and PERK/NOXA-mediated apoptosis in tumor cells by a dual mitochondrial-targeting mechanismHassan Choucair, Md Khalilur Rahman, Balasubrahmanyam Umashankar, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 1, 2019
Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cellsYassir Al-Zubaidi, Curtis Pazderka, Nooshin Koolaji, et al.
Biochemical Pharmacology|August 14, 2021
PTU, a novel ureido-fatty acid, inhibits MDA-MB-231 cell invasion and dissemination by modulating Wnt5a secretion and cytoskeletal signalingYassir Al-Zubaidi, Yongjuan Chen, Md Khalilur Rahman, et al.
Pageof 1